Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

Thumbnail

Cachexia common after stroke, linked to lower functional capacity

About 1 in 5 patients experienced cachexia—or a loss of muscle and body weight—within a year of acute ischemic stroke, according to a small, single-center study published Jan. 24 in the Journal of Cachexia, Sarcopenia and Muscle.

Thumbnail

3D-printed sugary stent boosts speed of suturing arteries

A team of researchers has developed a sugar-based stent that provides structural support during challenging microvascular suturing surgeries. The stent, which is 3D printed to match the diameters of specific arteries, fits inside the adjacent ends of a blood vessel while the stitching process takes place—and then quickly dissolves after blood flow resumes.

Thumbnail

Reperfusion suffers with in-hospital delays before stroke thrombectomy

Although the 2018 U.S. stroke guidelines recommended extending the window for endovascular thrombectomy (EVT) to 24 hours in select stroke patients, a new meta-analysis in JAMA Neurology serves as a reminder that prompt treatment remains crucial for achieving successful reperfusion.

Aspirin’s benefit in primary CVD prevention countered by bleeding risks

Aspirin offers modest protection against cardiovascular events in primary prevention, but that benefit is at least partially offset by an increase in major bleeding events, according to a meta-analysis published Jan. 22 in JAMA.

Thumbnail

5-year data show no link between paclitaxel dose and mortality with Medtronic DCB

Medtronic hopes newly presented five-year survival data put to rest any concerns about the long-term safety of the company’s IN.PACT Admiral drug-coated balloon (DCB).

Thumbnail

FDA to evaluate potential risks of paclitaxel-coated devices for PAD

The FDA is looking into the signal of increased late mortality associated with paclitaxel-coated balloons and stents that was observed in a recent meta-analysis of patients treated for femoropopliteal artery disease.

Thumbnail

Researchers ID risk factors for VTE in large-scale study

Older age, smoking and a higher body mass index (BMI) were consistently associated with a heightened risk of venous thromboembolism (VTE) in an analysis of 1.1 million individuals published in JAMA Cardiology.

Thumbnail

PTSD—especially from terror attacks—has lasting cardiovascular consequences

Long-term sufferers of post-traumatic stress disorder (PTSD) are at a higher risk for circulatory and metabolic diseases, especially if they’re men, according to research out of Siena, Italy.